L'intérêt à découvert pour Gossamer Bio donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Gossamer Bio. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Gossamer Bio (NASDAQ:GOSS) Stock, Rapport sur les intérêts à découvert

GOSSAMER BIO INC

Gossamer Bio

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Inc

GOSSAN RESOURCES LTD CDA by Gossan Resources Ltd.

Gossan Resources Ltd

Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has outperformed the market over the past 15 years by 3.88% on an annualized basis producing an average annual return of 16.26%. Currently, Oracle has a market capitalization of $643.78 billion. 
Buying $1000 In ORCL: If an investor had bought $1000 of ORCL stock 15 years ago, it would be worth $9,719.37 today based on a price of $229.20 for ORCL at the time of writing.
<h3>Oracle's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752536712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

ORCL

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Billionaire Elon Musk bought Twitter for<a href="https://www.benzinga.com/news/23/04/31810229/elon-musk-bought-twitter-1-year-ago-a-look-back-at-whats-happened-since-and-what-could-be-next"> $44 billion in 2022</a> and, along with changing the name of the social media platform to X, has made an increased focus on monetization for top posts and creators on the platform.
One user may see future revenue after a moment of viral fame on the platform.
What Happened: As the <a href="https://www.benzinga.com/general/social-media/24/10/41168674/elon-musk-passes-200-million-followers-on-x-heres-the-top-10-accounts-and-where-barack-obama">most followed person</a> on X, the posts and replies made by Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Musk can often go viral and lead to strong viewership for posts made by others.
X user @frozenaesthetic known as Moon Dragon found that out recently with a post made on April 1 that has now been seen over one billion times on the social media platform.
"On April 1st I put up a tweet then moved on from it, then it got retweeted 3 months later and now Elon Musk knows I exist," the user recently posted.
The <a href="https://x.com/frozenaesthetic/status/1907089552600093079">post </a>made by the user was: "share a piece of lore about yourself."
At the time of writing, the post has over 9,800 comments, 186,000 retweets and 114,000 likes.
X has not always shown the number of views on posts, but this may be the first to register the one billion milestone since that information became public.
"When I got hired at X in 2023 one of my first projects was to update the logic for number rounding on this app and I haven't seen billions in use until this post," X engineer Jonah Katz <a href="https://x.com/dinkin_flickaa/status/1944542448878834019">posted</a>.
Read Also: <a href="https://www.benzinga.com/news/social-media/25/07/46329375/x-ceo-yaccarino-splits-with-elon-musk-after-two-years-says-best-is-yet-to-come-for-social-platform">X CEO Yaccarino Splits With Elon Musk After Two Years, Says &#8216;Best Is Yet To Come&#8217; For Social Platform</a>
Best Lore Posts: The X user credits the post being seen by Musk and several of his companies and a large streamer for helping with the virality of the post. Here are some of the best tweets made about the post.
<a href="https://x.com/McDonalds/status/1943815403731657025">McDonald's </a>
"Grimace used to be called evil grimace and had 4 arms to hold more shakes."
<a href="https://x.com/comradeflynn/status/1942106466070188165">Comrade Flynn</a>
"I got really drunk in college 25+ years ago and made a banana dance to the song "Peanut Butter Jelly Time". I forgot about it for 3 days until my ISP called to ask what was happening as my site had been visited 4 million times and was growing."
<a href="https://x.com/gamestop/status/1943375801904402890">GameStop Corporation</a> 
"Boy do I have a story for you…"
They didn't share more of the story, but you can read <a href="https://www.benzinga.com/general/gaming/23/01/30412695/gamestop-short-squeeze-anniversary-a-look-back-at-david-vs-goliath-battle-and-whats-next">all about it here.</a>
<a href="https://x.com/MerriamWebster/status/1943325891901186313">Merriam Webster</a>
"We once made a dictionary with a built-in stand."
<a href="https://x.com/DrinkAriZona/status/1942699349819248879">Drink AriZona</a>
"We are from New York"
<a href="https://x.com/penguinusa/status/1942983777434882091">Penguin Books</a>
"When we first started publishing paperbacks in 1935, the color of the cover corresponded to the book's genre."
Singer <a href="https://x.com/dionnewarwick/status/1943047181427986689">Dionne Warwick</a>
"My name is Marie"
<a href="https://x.com/X/status/1942652662987776268">X</a>
"I used to a bird"
<a href="https://x.com/Tesla/status/1942656092565049440">Tesla</a>
"One of our cars is literally floating in space rn"
<a href="https://x.com/EmpireStateBldg/status/1942264128841900254">Empire State Building</a>
"I was climbed by a gigantic ape in 1933" (King Kong movie reference)
<a href="https://x.com/GWR/status/1943044964637638994">Guinness World Records</a>
"We were founded because two people couldn't agree on what the fastest bird was whilst they were out hunting"
Coinbase Global CEO and co-founder <a href="https://x.com/brian_armstrong/status/1942673835381383289">Brian Armstrong</a>
"The first version of Coinbase launched with just a hot wallet — a risky proposition. We were in beta and the app prominently told people not to store any money there they couldn't afford to lose."
(Armstrong's lore post is much lengthier than others and dives into the company's beginnings)
Internet Influencer <a href="https://x.com/greg16676935420/status/1942294237548273886">Greg16676935420</a>
"Ok fine it's time to explain it all Everyone always asks me what the 16676935420 stands for after greg in my username I've always kept it a secret but figure it's finally time I let the cat out of the bag and this post seems like a good place to do it 16676935420 stands for nothing. It's just random numbers since <a href="https://x.com/greg">@greg</a> was taken"
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/46134657/bye-bye-birdie-twitter-blue-bird-logo-blown-up-to-promote-online-marketplace-company">Bye Bye Birdie: Twitter Blue Bird Logo Blown Up To Promote Online Marketplace Company</a></li>
</ul>
Photo: Mamun_Sheikh via Shutterstock

Entertainment

Social Media

TSLA

Tesla, X, McDonald's Share Their Lore Stories: Social Media User With 26K Followers Gets 1 Billion Views

Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has outperformed the market over the past 20 years by 1.41% on an annualized basis producing an average annual return of 9.89%. Currently, Goldman Sachs Group has a market capitalization of $222.42 billion. 
Buying $100 In GS: If an investor had bought $100 of GS stock 20 years ago, it would be worth $650.76 today based on a price of $712.79 for GS at the time of writing.
<h3>Goldman Sachs Group's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752535812_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Goldman Sachs Group 20 Years Ago Would Be Worth This Much Today

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has outperformed the market over the past 20 years by 4.71% on an annualized basis producing an average annual return of 13.19%. Currently, FactSet Research Systems has a market capitalization of $16.73 billion. 
Buying $100 In FDS: If an investor had bought $100 of FDS stock 20 years ago, it would be worth $1,175.55 today based on a price of $440.01 for FDS at the time of writing.
<h3>FactSet Research Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752534911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning FactSet Research Systems Stock In The Last 20 Years

GFL Environmental (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>) has outperformed the market over the past 5 years by 4.94% on an annualized basis producing an average annual return of 19.13%. Currently, GFL Environmental has a market capitalization of $17.09 billion. 
Buying $100 In GFL: If an investor had bought $100 of GFL stock 5 years ago, it would be worth $245.48 today based on a price of $46.62 for GFL at the time of writing.
<h3>GFL Environmental's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752534012_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In GFL Environmental 5 Years Ago Would Be Worth Today

Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) has outperformed the market over the past 20 years by 1.18% on an annualized basis producing an average annual return of 9.66%. Currently, Western Digital has a market capitalization of $23.39 billion. 
Buying $1000 In WDC: If an investor had bought $1000 of WDC stock 20 years ago, it would be worth $6,102.09 today based on a price of $67.25 for WDC at the time of writing.
<h3>Western Digital's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752533116_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 33.76 percent. This is a 61.54 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $174.000 thousand which beat the analyst consensus estimate of $91.333 thousand by 90.51 percent. This is a 107.14 percent increase over sales of $84.000 thousand the same period last year.

Earnings

Earnings Beats

Earnings Misses

LEXX

Lexaria Bioscience Q3 EPS $(0.21) Misses $(0.16) Estimate, Sales $174.000K Beat $91.333K Estimate

Denmark is getting serious about deepfakes. The country plans to update its copyright laws to give people legal control over their own faces, voices and bodies.
<h2 class="wp-block-heading">New Rules Would Give Everyone Ownership Of Their Identity</h2>
The Danish government says this will make it easier for people to <a href="https://www.benzinga.com/25/02/43441666/cloudflare-introduces-one-click-tool-to-combat-deepfakes-and-misinformation">fight back</a> against AI-generated imitations shared online without their permission. The changes are backed by a wide majority in Parliament and are expected to be introduced this fall.
"Everybody has the right to their own body, their own voice and their own facial features, which is apparently not how the current law is protecting people against generative AI,"&nbsp; Denmark&#8217;s Culture Minister Jakob Engel-Schmidt told <a href="https://www.theguardian.com/technology/2025/jun/27/deepfakes-denmark-copyright-law-artificial-intelligence">The Guardian</a> last month.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
Deepfakes are realistic digital versions of people created with artificial intelligence. They can make it look like someone said or did something they never did. With AI tools getting more powerful and accessible, it's easier than ever to make convincing fake images, videos or audio.
According to The Guardian, the law would give Danes the right to ask platforms to take down any deepfake content made or posted without their consent. It would also protect artists from having their performances digitally copied without permission. Those affected could be entitled to compensation.
Parodies and satire would still be allowed, but anything that digitally imitates someone without consent for more serious or harmful use would no longer be legal.
"Human beings can be run through the digital copy machine and be misused for all sorts of purposes, and I'm not willing to accept that," Engel-Schmidt told The Guardian.
Trending: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
The minister also warned tech companies that if they don't follow the new law, they could face &#8220;severe fines.&#8221; If necessary, Denmark may escalate enforcement to the European Commission.
Engel-Schmidt said he hopes other European countries follow Denmark&#8217;s example. Now that Denmark has taken over the EU presidency, he plans to push this idea further across the continent.
<h2 class="wp-block-heading">U.S. Sending Mixed Signals On Deepfakes</h2>
While Denmark pushes for legal protections, the U.S. has taken a more <a href="https://www.benzinga.com/startups/24/10/41564331/the-u-s-government-keeps-warning-about-deepfakes-yet-the-pentagon-wants-to-flood-social-media-with-a">contradictory path</a>. U.S. officials have repeatedly warned that deepfakes threaten national security, democracy and trust in public institutions. Just last year, three U.S. agencies issued a joint <a href="https://media.defense.gov/2023/Sep/12/2003298925/-1/-1/0/CSI-DEEPFAKE-THREATS.PDF">statement</a> calling deepfakes a "top risk."
See Also: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<a href="https://theintercept.com/2024/10/17/pentagon-ai-deepfake-internet-users/">The Intercept</a> reported last year that the Pentagon, through its Joint Special Operations Command, has been actively developing its own deepfake technology. According to internal <a href="https://www.documentcloud.org/documents/25224425-jsoc-stylegan-personas/">documents</a>, the U.S. military is creating AI-generated personas that can operate on social media, share posts, and even record lifelike selfie videos.
These fake profiles are designed to be indistinguishable from real people, complete with "government identification quality" photos and elaborate backstories. The goal, allegedly, is to use these avatars to blend into online spaces and influence opinion, the same type of manipulation the U.S. condemns when used by adversaries like China, Russia and Iran.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

Denmark Is Taking On AI By Letting People Copyright Their Own Faces. In A World Of Deepfakes, It's A Radical Step

Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) has outperformed the market over the past 15 years by 1.24% on an annualized basis producing an average annual return of 13.62%. Currently, Gilead Sciences has a market capitalization of $139.43 billion. 
Buying $100 In GILD: If an investor had bought $100 of GILD stock 15 years ago, it would be worth $681.19 today based on a price of $112.09 for GILD at the time of writing.
<h3>Gilead Sciences's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752532212_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GILD

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

GoldMining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GLDG#AMEX">GLDG</a>) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent increase over losses of $(0.02) per share from the same period last year.

GLDG

GoldMining Q2 EPS $(0.01) Beats $(0.02) Estimate

Orkla (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ORKLY#OTC">ORKLY</a>) reported quarterly earnings of $0.15 per share. This is unchanged from the same period last year. The company reported $1.712 billion in sales this quarter. This is a 6.80 percent increase over sales of $1.603 billion the same period last year.

ORKLY

Orkla Q2 Adj. EPS $0.15, Same YoY, Sales $1.712B Up From $1.603B YoY

CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) has outperformed the market over the past 10 years by 9.41% on an annualized basis producing an average annual return of 20.83%. Currently, CyberArk Software has a market capitalization of $19.01 billion. 
Buying $100 In CYBR: If an investor had bought $100 of CYBR stock 10 years ago, it would be worth $685.76 today based on a price of $377.89 for CYBR at the time of writing.
<h3>CyberArk Software's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752531311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CYBR

$100 Invested In CyberArk Software 10 Years Ago Would Be Worth This Much Today

Editor&#8217;s Note: The story ahs been updated to include post-split accounting in para 6
DeFi Development Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) stock gained on Monday after it issued its first <a href="https://www.benzinga.com/topic/solana" target="_blank" rel="noreferrer noopener">forward-looking guidance</a> on Solana (CRYPTO: SOL/USD) per Share (SPS), the company&#8217;s primary performance metric.
DeFi Development outlined a medium-term objective of reaching 1.0 SPS by December 2028 and near-term guidance of 0.1650 SPS by June 2026, representing approximately 261% growth from Monday&#8217;s level of 0.0457.
As part of its ongoing accumulation strategy, the company also announced it had purchased an additional 10,758 SOL at an average price of $161.30.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/25/05/45217853/exclusive-defi-development-corp-expands-digital-asset-portfolio-holds-58-5-million-in-solana-tokens" rel="noreferrer noopener">DeFi Development Corp Expands Digital Asset Portfolio, Holds $58.5 Million In Solana Tokens</a>
On May 12, DeFi Development announced <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/25/05/45344230/exclusive-defi-development-makes-record-solana-purchase-surpasses-100-million-in-treasury-holdings" rel="noreferrer noopener">it had purchased</a> 172,670 SOL at an average purchase price of $136.81, valued at&nbsp;approximately $23.6 million.
This marks the company&#8217;s tenth Solana purchase under its digital asset treasury strategy and its largest purchase. DeFi Development held 595,988 SOL, valued at approximately $102.7 million then.
As of May 12, DeFi Development had 2.04 million total outstanding shares. The SPS was 0.293, or $50.42. These figures equate to 0.0418 SPS, or $7.20, when accounting for DeFi Dev Corp.&#8217;s seven-for-one stock split on May 19.
Price Action: DFDV stock traded higher by 3.49% to $28.20 premarket at the last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/upgrades/25/07/46373610/amc-stock-just-got-upgrade-could-premium-screens-box-office-momentum-signal-a-comeback" target="_blank" rel="noreferrer noopener">AMC Stock Just Got Upgrade — Could Premium Screens, Box Office Momentum Signal A Comeback?</a></li>
</ul>
Photo by Lee Wa Da via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Guidance

Exclusives

DFDV

EXCLUSIVE: DeFi Development Issues First Outlook, Targets 1.0 SPS By 2028 (UPDATED)

13 analysts have expressed a variety of opinions on Five9 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $33.54, with a high estimate of $40.00 and a low estimate of $23.00. Observing a downward trend, the current average is 27.61% lower than the prior average price target of $46.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1752530460_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Five9 among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Jackson Ader</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$35.00</td>
<td>-</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$36.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Taylor McGinnis</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$35.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Peter Levine</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$36.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$40.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$28.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Catharine Trebnick</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$36.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$23.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Five9. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Five9 compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Five9's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FIVN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Five9 analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Five9</h2>
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
<h3>Five9: Delving into Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Five9 displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 13.24%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Five9's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.21%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Five9's ROE stands out, surpassing industry averages. With an impressive ROE of 0.09%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Five9's ROA stands out, surpassing industry averages. With an impressive ROA of 0.03%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Five9's debt-to-equity ratio is below the industry average at 1.86, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

FIVN

Deep Dive Into Five9 Stock: Analyst Perspectives (13 Ratings)

During the last three months, 11 analysts shared their evaluations of Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Cava Group, revealing an average target of $110.91, a high estimate of $125.00, and a low estimate of $90.00. Observing a downward trend, the current average is 8.72% lower than the prior average price target of $121.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1752530452_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Cava Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Harbour</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$107.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Christopher Carril</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$100.00</td>
<td>-</td>
</tr>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$95.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Chris O'Cull</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$125.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Sara Senatore</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$121.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$115.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>David Tarantino</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$120.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$112.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$90.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Andrew Charles</td>
<td>TD Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$130.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Cava Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cava Group compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Cava Group's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Cava Group's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CAVA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cava Group analyst ratings.</a>
<h2>Unveiling the Story Behind Cava Group</h2>
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
<h3>Cava Group: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Cava Group's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 28.12%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Cava Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.75% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Cava Group's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.62%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Cava Group's ROA stands out, surpassing industry averages. With an impressive ROA of 2.14%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Cava Group's debt-to-equity ratio is below the industry average at 0.57, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CAVA

Assessing Cava Group: Insights From 11 Financial Analysts

Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) has been analyzed by 10 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $640.8, with a high estimate of $670.00 and a low estimate of $610.00. Observing a downward trend, the current average is 0.41% lower than the prior average price target of $643.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1752530445_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Mastercard. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeff Cantwell</td>
<td>Seaport Global</td>
<td>Maintains</td>
<td>Buy</td>
<td>$616.00</td>
<td>$616.00</td>
</tr>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$670.00</td>
<td>$660.00</td>
</tr>
<tr>
<td>Matthew Coad</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$640.00</td>
<td>-</td>
</tr>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$660.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Trevor Williams</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$655.00</td>
<td>$630.00</td>
</tr>
<tr>
<td>Andrew Schmidt</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$652.00</td>
<td>$650.00</td>
</tr>
<tr>
<td>Trevor Williams</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$630.00</td>
<td>$660.00</td>
</tr>
<tr>
<td>Timothy Chiodo</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$640.00</td>
<td>$660.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$635.00</td>
<td>$630.00</td>
</tr>
<tr>
<td>Paul Golding</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$610.00</td>
<td>$645.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Mastercard. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Mastercard compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Mastercard's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Mastercard's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Mastercard analyst ratings.</a>
<h2>All You Need to Know About Mastercard</h2>
Mastercard is the second-largest payment processor in the world, having processed close to $10 trillion in volume during 2024. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.
<h3>Financial Milestones: Mastercard's Journey</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Mastercard's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 14.21%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Mastercard's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 45.24%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Mastercard's ROE excels beyond industry benchmarks, reaching 49.86%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Mastercard's ROA excels beyond industry benchmarks, reaching 6.79%. This signifies efficient management of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.82, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Mastercard Through The Eyes Of 10 Analysts

Ratings for ITT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITT#NYSE">ITT</a>) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $170.83, a high estimate of $186.00, and a low estimate of $160.00. This current average reflects an increase of 11.05% from the previous average price target of $153.83. 
<img src="https://www.benzinga.com/files/images/story/2025/1752530436_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive ITT. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$186.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$177.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$171.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$161.00</td>
<td>$148.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to ITT. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of ITT compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of ITT's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into ITT's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ITT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ITT analyst ratings.</a>
<h2>Get to Know ITT Better</h2>
ITT began its journey as International Telephone &amp; Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
<h3>Breaking Down ITT's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining ITT's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.26% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: ITT's net margin is impressive, surpassing industry averages. With a net margin of 11.87%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): ITT's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.91%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): ITT's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.27%, the company showcases efficient use of assets and strong financial health.
Debt Management: ITT's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.3.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ITT Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

Analysts' ratings for Super Group (SGHC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $13.0, with a high estimate of $15.00 and a low estimate of $11.00. This current average has increased by 15.15% from the previous average price target of $11.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1752530428_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Super Group (SGHC). The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jordan Bender</td>
<td>JMP Securities</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$15.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Tilchen</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Clark Lampen</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$11.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$11.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Jason Tilchen</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Jason Tilchen</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Mike Hickey</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Super Group (SGHC). This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Super Group (SGHC) compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Super Group (SGHC)'s stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Super Group (SGHC)'s market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SGHC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Super Group (SGHC) analyst ratings.</a>
<h2>Discovering Super Group (SGHC): A Closer Look</h2>
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.
<h3>Super Group (SGHC)'s Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Super Group (SGHC)'s financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 25.49% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Super Group (SGHC)'s net margin is impressive, surpassing industry averages. With a net margin of 11.41%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 9.63%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Super Group (SGHC)'s financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 5.41%, the company showcases efficient use of assets and strong financial health.
Debt Management: Super Group (SGHC)'s debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.11.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SGHC

Beyond The Numbers: 8 Analysts Discuss Super Group (SGHC) Stock

Looking into the current session, DHT Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHT#NYSE">DHT</a>) shares are trading at $11.20, after a 0.10% drop. Over the past month, the stock decreased by 8.16%, but over the past year, it actually increased by 0.45%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1752530417_0.png" alt="Past Year Chart" />

<h3>How Does DHT Holdings P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 13.16 in the Oil, Gas &amp; Consumable Fuels industry, DHT Holdings Inc. has a lower P/E ratio of 10.19. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1752530417_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: DHT Holdings

5 analysts have shared their evaluations of Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $663.8, with a high estimate of $785.00 and a low estimate of $592.00. This current average has increased by 10.34% from the previous average price target of $601.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1752530415_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Goldman Sachs Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Fitzgerald</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$600.00</td>
<td>$600.00</td>
</tr>
<tr>
<td>Saul Martinez</td>
<td>HSBC</td>
<td>Raises</td>
<td>Reduce</td>
<td>$627.00</td>
<td>$558.00</td>
</tr>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$785.00</td>
<td>$650.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$715.00</td>
<td>$630.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$592.00</td>
<td>$570.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Goldman Sachs Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Goldman Sachs Group compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Goldman Sachs Group's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Goldman Sachs Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/GS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Goldman Sachs Group analyst ratings.</a>
<h2>Delving into Goldman Sachs Group's Background</h2>
Goldman Sachs is a storied financial institution, founded in 1869 and best known for its role as a leading global investment bank. The firm has a sprawling reach across global financial centers and has been the leading provider of global merger and acquisition advisory services, by revenue, for the past 20 years. Since the global financial crisis, Goldman has expanded its offerings into more stable fee-based businesses like asset and wealth management, which comprised roughly 30% of post-provision revenue at the end of 2024. The bank holding company generates revenue from investment banking, global market making and trading, lending, asset management, wealth management, and a small and declining portfolio of consumer credit card loans.
<h3>Goldman Sachs Group: A Financial Overview</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Goldman Sachs Group's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.97% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Goldman Sachs Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 30.43%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Goldman Sachs Group's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 4.21%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.27%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 3.31, Goldman Sachs Group faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Goldman Sachs Group Through 5 Analysts

Press Releases

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH

ASPI

ATCH

BIXT

CLNN

CSE:HG

FFAI

GOSS

HDRSF

HGRAF

HSCS

JAGX

MDNAF

MNMRF

MTVA

NCSM

ONFO

PBEGF

RGBP

RMETF

SEVCF

TNMG

TSX:MDNA

TSX:TXP

TSXV:HI

TSXV:MNRG

TSXV:RAK

TSXV:UCU

TSXV:VROY

TSXV:WRLG

TZUP

UURAF

VROYF

WRLGF

WYTC

XXII

Abeona Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Altimmune

Annexon

Benitec Biopharma

Candel Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Foghorn Therapeutics

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Heron Therapeutics

Inhibrx Biosciences

Neurogene

Ocugen

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Sagimet Biosciences Inc. - Series A Common Stock

Sagimet Biosciences

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Vanda Pharmaceuticals Inc. - Common Stock

Vanda Pharmaceuticals

Vor Biopharma

XOMA Royalty

Scotiabank

Goldman Sachs

Wedbush

HC Wainwright & Co.

Oppenheimer

WIIM

Gossamer Bio shares are trading higher after Scotiabank initiated coverage on the stock with a Sector Outperform rating and announced a price target of $11.

Comments

Gossamer Bio

Intérêt court

Gossamer Bio (NASDAQ:GOSS) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL